Context & challenge
The service started in October 2016 and has been strengthened over the years. A major French Pharmaceutical company has entrusted with several activities, namely the management of part of the spontaneous cases, literature review and case management, Eudravigilance monitoring and processing of part of EV cases as well as SDEA reconciliations.
Currently, the company portfolio includes 1271 products marketed in France and 265 products marketed in 14 countries outside France.
- Spontaneous and literature case management
- Identification and management of EV cases
(EVWEB and MLM)
- Global and local literature (300 DCI / 2 databases and 15 FR local journals